Should a 19-year-old with abrasions from a bicycle accident receive a tetanus booster (Tdap/Td)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tetanus Booster Recommendation for 19-Year-Old with Bicycle Abrasions

A tetanus booster is recommended for this 19-year-old if more than 5 years have passed since their last tetanus-containing vaccine. 1

Decision Algorithm

The decision to administer tetanus prophylaxis depends on two key factors:

  1. Time since last tetanus vaccination
  2. Wound characteristics (clean/minor vs. all other wounds)

For This Patient's Abrasions

Abrasions from a bicycle accident are considered tetanus-prone wounds (not clean and minor) because they likely involve dirt or environmental contamination 2. For such wounds:

  • If ≥5 years since last tetanus vaccine: Administer Tdap or Td 1
  • If <5 years since last tetanus vaccine: No tetanus vaccine needed 1

Vaccine Selection

If the patient has never received Tdap: Give Tdap (preferred over Td) 1

If the patient previously received Tdap: Either Tdap or Td is acceptable 1

The 2020 ACIP guidelines updated recommendations to allow flexibility in using either Tdap or Td for wound management in patients who previously received Tdap, whereas previously only Td was recommended in this scenario 1.

Critical Considerations

Vaccination History Assessment

You must determine:

  • Has the patient completed primary tetanus series? (3 doses)
  • When was the last tetanus-containing vaccine?
  • Has the patient ever received Tdap?

If vaccination history is unknown or uncertain, treat the patient as having received no previous tetanus vaccination 2, 3. This would require:

  • Tdap dose now
  • Td or Tdap at ≥4 weeks
  • Td or Tdap at 6-12 months 1

Tetanus Immune Globulin (TIG)

TIG is NOT needed if the patient has completed a primary tetanus series (3 doses), regardless of time since last dose 2, 3.

TIG IS indicated (250 units IM) only if:

  • Primary vaccination series is incomplete or unknown
  • AND the wound is tetanus-prone 2

Common Pitfalls to Avoid

  1. Don't delay vaccination if indicated—there is no need to wait for "optimal timing." The vaccine should be given during the wound management visit 1

  2. Don't confuse the 5-year and 10-year intervals:

    • 5 years applies to tetanus-prone wounds 1
    • 10 years applies to routine boosters and clean/minor wounds 1
  3. Don't assume young adults are up-to-date: Many 19-year-olds may not have received their adolescent Tdap booster recommended at age 11-12 years 1

  4. Don't give TIG unnecessarily: Most patients with wounds who seek medical care have completed primary vaccination and do NOT need TIG 2. Only 2.3% of eligible patients actually received TIG in surveillance data 4

Clinical Context

Tetanus remains a serious disease with a 12.4% case-fatality rate in the United States 4. During 2009-2023,402 tetanus cases were reported, with 43.9% occurring in persons who had received no tetanus-containing vaccine doses 4. Among patients with wounds who sought medical care before tetanus onset, only 26% received appropriate TTCV prophylaxis 4, highlighting the importance of proper wound management protocols.

The key clinical decision point is the 5-year threshold for tetanus-prone wounds—if this patient's last tetanus vaccine was ≥5 years ago, vaccinate now with Tdap (if never received) or Tdap/Td (if previously received Tdap) 1.

Related Questions

What are the recommended Tdap (tetanus, diphtheria, acellular pertussis) vaccination schedules for adults, pregnant women, wound prophylaxis, and immunocompromised patients?
Should a patient receive a tetanus-diphtheria-pertussis (Tdap) booster after cutting her foot on a metal rod in public transportation, given that her last Tdap was eight years ago?
What is the optimal management, including antibiotic regimen and tetanus‑diphtheria‑pertussis (Tdap) vaccination, for a 60-year-old man with a hammer puncture wound to the thumb who last received Tdap on [DATE]?
When should a Tdap (tetanus, diphtheria, acellular pertussis) vaccine be given after sustaining a ground abrasion?
What tetanus‑diphtheria‑pertussis (Tdap) vaccine can be given to a 13‑year‑old?
In a patient with recent clot formation requiring mesh placement, ongoing internal bleeding, and who has been NPO for more than one week, is initiation of total parenteral nutrition appropriate?
In an adult male taking lithium 1200 mg daily, is a serum lithium level of 1.0 mmol/L (or mEq/L) within the therapeutic range?
What is the recommended dosing regimen and safety considerations for semaglutide (Ozempic) injections for weight loss in an adult without contraindications?
A patient taking warfarin 2 mg on Thursday, Saturday, and Sunday and 4 mg on other days has a Wednesday INR of 2.7 and a Thursday INR of 3.0 (target INR 2–3 for atrial fibrillation). Should I give an additional 0.5 mg, 1 mg, or omit the dose today?
How can I conduct pre‑eclampsia problem‑based learning in primary care for a pregnant woman in her first or second trimester who has risk factors such as nulliparity, chronic hypertension, pre‑gestational diabetes, renal disease, obesity, or a prior episode of pre‑eclampsia?
How should polyclonal T‑cell receptor gamma (TRG) gene rearrangements (all <2.5% of reads) be interpreted in a patient with hairy cell leukemia, and does this finding require any change in management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.